TraceLink Inc., the world’s largest track and trace network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, has announced that the Life Sciences Cloud has received the 2015 CPhI Pharma Award for Innovation in Supply Chain and Logistic Management.
The 2015 CPhI Pharma Awards, held in Madrid, Spain on 13 October, recognize pharmaceutical companies that turn inspiration into innovation and celebrate thinkers and creators breaking new ground in formulation, process development, packaging, technology and more. After the company was selected as one of 16 finalists, Jean-Marie Aulnette, Vice President, EMEA at TraceLink presented the Life Sciences Cloud solution to a jury of industry judges in Madrid, and later accepted the award during an evening reception.
“We’re honoured that CPhI has recognized TraceLink as an innovative supply chain pioneer, particularly in a year where more than 70 companies were evaluated,” said Shabbir Dahod, President and CEO of TraceLink. “As one of only seven companies to receive CPhI’s top honour this year, this award demonstrates how unique and effective the Life Sciences Cloud is at enabling the entire pharmaceutical supply chain to meet track and trace regulations anywhere in the world, and ensure that life-saving medicines reach patients in the most secure and timely manner possible.”
The TraceLink Life Sciences Cloud is a network platform that pharmaceutical manufacturers, wholesalers, repackagers and pharmacies trust to deliver safe medicines to patients everywhere. A single point and click connection to the Life Sciences Cloud allows nearly 200,000 pharmaceutical suppliers — from the largest drug manufacturers to the smallest pharmacies — to gain complete global connectivity with all of their supply chain trading partners. TraceLink customers are able to take advantage of a fully integrated suite of applications for global serialization, track and trace, and government reporting solutions to achieve compliance and minimize risk.
Every year, CPhI recognizes technologies, systems and services that present new, innovative options for drug manufacturing, formulation and process developments, APIs and excipients, packaging, supply chain and logistics, and outsourcing. This year, there were more than 70 entries across different categories for the CPhI awards, of which only seven were crowned as winners.
The jury that rigorously interviewed the 16 finalists for CPhI Pharma Awards, comprised industry experts, including Dr Michael Platscher, Merck & Cie, Dr Hendrik Baumann, Arevipharma GmbH, Mrs. Veronique Bregeon, Merial, a Sanofi company, and Dr. Rene Bommer, pharmAccel Consulting.